Skip to content

TANG CAPITAL MANAGEMENT LLC

Follow

13F filer, CIK 1232621, SAN DIEGO, CA

TANG CAPITAL MANAGEMENT LLC reported $2,173,767,967 across 45 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 64.25% of the portfolio.

Accepted , ingested 13F-HR 0001214659-26-014410

Period
2026-09-30
Reported value
$2.17B
Holdings
45
Top 10 weight
64.25%
New
6
Sold out
2

Part of the filer group TANG CAPITAL MANAGEMENT LLC

  • TANG KEVIN
  • TANG CAPITAL PARTNERS III, INC
  • TANG CAPITAL PARTNERS INTERNATIONAL, LP
  • TANG CAPITAL PARTNERS IV, INC
  • TANG CAPITAL PARTNERS, LP
How groups are built

Stakes and trades reported after 2026-09-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • INO INOVIO PHARMACEUTICALS INC: 13G 17,978,200 shares, 9.99% of the class, 13G filed 2026-11-16, 0001214659-26-014444Timeline
    Accepted , ingested
  • EYPT EYEPOINT INC: 13G 8,250,200 shares, 9.6% of the class, 13G filed 2026-10-27, 0001214659-26-013297Timeline
    Accepted , ingested

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ARDXnew+9,047,134$30.9M
TARSadded+349,400$27.5M
VERAnew+500,000$16.1M
LEGNnew+700,000$13.9M
CELCadded+150,000$11.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
CAPRexited-4,099,900-$98.7M
SPYreduced-28,000-$21.4M
WVEexited-600,000-$3.49M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001214659-26-014410, largest first. % of portfolio is the value over $2,173,767,967, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
AUPHAURINIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,429,500 shares; 2025Q1: 10,029,500 shares; 2025Q2: 10,029,500 shares; 2025Q3: 11,329,500 shares; 2025Q4: 11,329,500 shares; 2026Q1: 12,229,500 shares; 2026Q2: 13,044,106 shares; 2026Q3: 13,044,106 shares 13,044,106$211M9.72%0Timeline
CORTCORCEPT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 156,764 shares; 2026Q1: 1,500,000 shares; 2026Q2: 1,500,000 shares; 2026Q3: 1,500,000 shares 1,500,000$173M7.95%0Timeline
KNSAKINIKSA PHARMACEUTICALS INTLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 628,609 shares; 2025Q1: 2,118,579 shares; 2025Q2: 2,328,609 shares; 2025Q3: 2,328,609 shares; 2025Q4: 2,259,889 shares; 2026Q1: 2,259,889 shares; 2026Q2: 2,259,889 shares; 2026Q3: 2,259,889 shares 2,259,889$169M7.76%0Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 2,050,000 shares; 2025Q2: 3,200,000 shares; 2025Q3: 3,200,000 shares; 2025Q4: 1,892,200 shares; 2026Q1: 1,892,200 shares; 2026Q2: 1,892,200 shares; 2026Q3: 1,892,200 shares 1,892,200$168M7.75%0Timeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,254,797 shares; 2025Q1: 2,454,797 shares; 2025Q2: 2,454,797 shares; 2025Q3: 2,454,797 shares; 2025Q4: 1,188,624 shares; 2026Q1: 1,188,624 shares; 2026Q2: 1,568,266 shares; 2026Q3: 1,917,666 shares 1,917,666$151M6.93%+349,400Timeline
LKFTLAKEFRONT BIOTHERAPEUTICS NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,161,200 shares; 2025Q1: 3,961,797 shares; 2025Q2: 3,990,111 shares; 2025Q3: 4,151,194 shares; 2025Q4: 3,921,219 shares; 2026Q1: 3,785,991 shares; 2026Q2: 3,785,991 shares; 2026Q3: 3,985,991 shares 3,985,991$118M5.44%+200,000Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,150,000 shares; 2025Q4: 1,050,000 shares; 2026Q1: 1,050,000 shares; 2026Q2: 1,314,594 shares; 2026Q3: 1,464,594 shares 1,464,594$116M5.36%+150,000Timeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,237,107 shares; 2025Q1: 1,237,107 shares; 2025Q2: 1,236,027 shares; 2025Q3: 1,236,027 shares; 2025Q4: 1,236,027 shares; 2026Q1: 1,236,027 shares; 2026Q2: 1,236,027 shares; 2026Q3: 1,236,027 shares 1,236,027$106M4.86%0Timeline
PTCTPTC THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 700,000 shares; 2025Q1: 1,000,000 shares; 2025Q2: 1,100,000 shares; 2025Q3: 1,500,000 shares; 2025Q4: 1,500,000 shares; 2026Q1: 1,500,000 shares; 2026Q2: 1,500,000 shares; 2026Q3: 1,500,000 shares 1,500,000$97.2M4.47%0Timeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,555,600 shares; 2025Q1: 1,915,708 shares; 2025Q2: 2,105,608 shares; 2025Q3: 2,305,608 shares; 2025Q4: 2,628,538 shares; 2026Q1: 2,649,368 shares; 2026Q2: 2,649,368 shares; 2026Q3: 2,884,149 shares 2,884,149$87.4M4.02%+234,781Timeline
ANABANAPTYSBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,330,879 shares; 2025Q1: 1,545,153 shares; 2025Q2: 1,330,879 shares; 2025Q3: 1,333,639 shares; 2025Q4: 1,332,087 shares; 2026Q1: 1,330,879 shares; 2026Q2: 1,330,879 shares; 2026Q3: 1,474,262 shares 1,474,262$74.1M3.41%+143,383Timeline
SPYSTATE STR SPDR S&P 500 ETF TQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 30,000 shares; 2026Q1: 168,000 shares; 2026Q2: 123,000 shares; 2026Q3: 95,000 shares 95,000$72.4M3.33%-28,000Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,000,000 shares; 2025Q1: 1,400,000 shares; 2025Q2: 1,300,000 shares; 2025Q3: 2,200,000 shares; 2025Q4: not reported; 2026Q1: 4,002,200 shares; 2026Q2: 5,000,000 shares; 2026Q3: 5,200,000 shares 5,200,000$64.7M2.98%+200,000Timeline
PGENPRECIGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 12,400,000 shares; 2025Q4: 5,617,500 shares; 2026Q1: 6,417,500 shares; 2026Q2: 6,417,500 shares; 2026Q3: 6,417,500 shares 6,417,500$54.9M2.53%0Timeline
ANIPANI PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 317,500 shares; 2025Q1: 317,500 shares; 2025Q2: 317,500 shares; 2025Q3: 317,500 shares; 2025Q4: 481,437 shares; 2026Q1: 707,500 shares; 2026Q2: 707,500 shares; 2026Q3: 707,500 shares 707,500$51.4M2.36%0Timeline
BNTXBIONTECH SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 270,000 shares; 2025Q1: 270,000 shares; 2025Q2: 270,000 shares; 2025Q3: 270,000 shares; 2025Q4: 470,000 shares; 2026Q1: 470,000 shares; 2026Q2: 470,000 shares; 2026Q3: 470,000 shares 470,000$46.2M2.13%0Timeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,492,925 shares; 2025Q1: 2,792,925 shares; 2025Q2: 2,842,925 shares; 2025Q3: 2,842,925 shares; 2025Q4: 1,792,626 shares; 2026Q1: 1,792,626 shares; 2026Q2: 1,792,626 shares; 2026Q3: 1,792,626 shares 1,792,626$36.9M1.7%0Timeline
NVCTNUVECTIS PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,550,000 shares; 2026Q3: 1,577,968 shares 1,577,968$33.3M1.53%+27,968Timeline
NNDMNANO DIMENSION LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 14,292,813 shares; 2026Q3: 20,926,847 shares 20,926,847$32.9M1.51%+6,634,034Timeline
ARDXARDELYX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 9,047,134 shares 9,047,134$30.9M1.42%new2026-11-09, 13G: 14,336,247 shares, 5.7% of the class, 13G filed 2026-11-17 Timeline
FULCFULCRUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 6,521,412 shares; 2026Q3: 7,080,945 shares 7,080,945$26.2M1.21%+559,533Timeline
AVIRATEA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,788,912 shares; 2025Q1: 4,800,000 shares; 2025Q2: 4,889,200 shares; 2025Q3: 4,826,200 shares; 2025Q4: 4,814,700 shares; 2026Q1: 4,814,700 shares; 2026Q2: 4,814,700 shares; 2026Q3: 4,814,700 shares 4,814,700$25.1M1.15%02026-10-06, 13G: 4,814,700 shares, 6% of the class, 13G filed 2026-10-06 Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 264,692 shares; 2025Q1: 264,692 shares; 2025Q2: 264,692 shares; 2025Q3: 264,692 shares; 2025Q4: 264,692 shares; 2026Q1: 264,692 shares; 2026Q2: 264,692 shares; 2026Q3: 264,692 shares 264,692$23.3M1.07%0Timeline
CMPXCOMPASS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,900,000 shares; 2025Q1: 11,052,632 shares; 2025Q2: 13,496,208 shares; 2025Q3: 16,811,963 shares; 2025Q4: 16,790,809 shares; 2026Q1: 16,790,809 shares; 2026Q2: 17,990,782 shares; 2026Q3: 17,990,782 shares 17,990,782$18.7M0.86%0Timeline
NUVBNUVATION BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,900,000 shares; 2025Q1: 3,900,000 shares; 2025Q2: 3,900,000 shares; 2025Q3: 4,200,000 shares; 2025Q4: 3,857,457 shares; 2026Q1: 3,149,557 shares; 2026Q2: 3,299,557 shares; 2026Q3: 3,299,557 shares 3,299,557$18.5M0.85%0Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 400,000 shares; 2025Q4: 450,000 shares; 2026Q1: 450,000 shares; 2026Q2: 450,000 shares; 2026Q3: 450,000 shares 450,000$17.3M0.8%0Timeline
CBIOCRESCENT BIOPHARMA INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 50,152 shares; 2025Q3: 679,824 shares; 2025Q4: 872,398 shares; 2026Q1: 1,160,000 shares; 2026Q2: 1,160,000 shares; 2026Q3: 1,160,000 shares 1,160,000$16.9M0.78%0Timeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 320,000 shares; 2025Q1: 270,000 shares; 2025Q2: 370,000 shares; 2025Q3: 870,000 shares; 2025Q4: 500,000 shares; 2026Q1: 500,000 shares; 2026Q2: 500,000 shares; 2026Q3: 500,000 shares 500,000$16.3M0.75%0Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 150,000 shares; 2025Q2: 1,350,000 shares; 2025Q3: 1,350,000 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 500,000 shares 500,000$16.1M0.74%newTimeline
LEGNLEGEND BIOTECH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 450,000 shares; 2025Q1: 830,000 shares; 2025Q2: 830,000 shares; 2025Q3: 830,000 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 700,000 shares 700,000$13.9M0.64%newTimeline
PMVPPMV PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 4,785,201 shares; 2025Q4: 4,940,000 shares; 2026Q1: 4,245,085 shares; 2026Q2: 4,245,085 shares; 2026Q3: 7,285,085 shares 7,285,085$12.2M0.56%+3,040,000Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 100,000 shares; 2025Q1: 100,000 shares; 2025Q2: 200,000 shares; 2025Q3: 200,000 shares; 2025Q4: 60,000 shares; 2026Q1: 260,000 shares; 2026Q2: 100,000 shares; 2026Q3: 100,000 shares 100,000$11.4M0.53%0Timeline
DERMJOURNEY MED CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,725,569 shares; 2025Q1: 1,854,596 shares; 2025Q2: 1,854,596 shares; 2025Q3: 1,854,596 shares; 2025Q4: 1,854,596 shares; 2026Q1: 1,610,000 shares; 2026Q2: 1,610,000 shares; 2026Q3: 1,610,000 shares 1,610,000$11M0.51%0Timeline
MRNAMODERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 300,000 shares; 2025Q1: 305,300 shares; 2025Q2: 305,300 shares; 2025Q3: 305,300 shares; 2025Q4: 692,820 shares; 2026Q1: 100,000 shares; 2026Q2: 50,000 shares; 2026Q3: 50,000 shares 50,000$9.63M0.44%0Timeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 300,000 shares; 2025Q1: 500,000 shares; 2025Q2: 500,000 shares; 2025Q3: 500,000 shares; 2025Q4: 500,000 shares; 2026Q1: 500,000 shares; 2026Q2: 300,000 shares; 2026Q3: 300,000 shares 300,000$7.8M0.36%0Timeline
BOLDBOUNDLESS BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,559,875 shares; 2026Q3: 2,840,635 shares 2,840,635$7.13M0.33%+280,7602026-11-20, Form 4: bought 39,920 shares on 2026-11-20 Timeline
PLRXPLIANT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 6,000,000 shares; 2025Q2: 6,000,000 shares; 2025Q3: 6,003,446 shares; 2025Q4: 6,143,132 shares; 2026Q1: 6,143,132 shares; 2026Q2: 6,141,261 shares; 2026Q3: 6,141,261 shares 6,141,261$6.63M0.31%0Timeline
HRTXHERON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,140,271 shares; 2025Q1: 2,235,459 shares; 2025Q2: 2,135,459 shares; 2025Q3: 3,450,000 shares; 2025Q4: 6,250,000 shares; 2026Q1: 6,250,000 shares; 2026Q2: 6,250,000 shares; 2026Q3: 8,971,427 shares 8,971,427$2.81M0.13%+2,721,427Timeline
WVEWAVE LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 600,000 shares 600,000$2.22M0.1%newTimeline
ALTALTIMMUNE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,750,000 shares; 2025Q1: 2,750,000 shares; 2025Q2: 2,750,000 shares; 2025Q3: 2,131,307 shares; 2025Q4: 2,131,307 shares; 2026Q1: 666,022 shares; 2026Q2: 666,022 shares; 2026Q3: 666,022 shares 666,022$1.9M0.09%0Timeline
LENZLENZ THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 766,940 shares; 2025Q1: 766,940 shares; 2025Q2: 897,616 shares; 2025Q3: 897,616 shares; 2025Q4: 865,169 shares; 2026Q1: 451,114 shares; 2026Q2: 451,114 shares; 2026Q3: 451,114 shares 451,114$1.73M0.08%0Timeline
SIONSIONNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 125,000 shares 125,000$658K0.03%newTimeline
SKYESKYE BIOSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 200,000 shares 200,000$322K0.01%new2026-10-07, 13G: 263,560 shares, 6% of the class, 13G filed 2026-10-14 Timeline
RCKTROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 750,000 shares; 2025Q1: 850,000 shares; 2025Q2: 850,000 shares; 2025Q3: 850,000 shares; 2025Q4: 100,000 shares; 2026Q1: 100,000 shares; 2026Q2: 100,000 shares; 2026Q3: 100,000 shares 100,000$263K0.01%0Timeline

Principal amounts

Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).

SecurityTypeAmountValueChange
GOSSAMER BIO INCGOSSAMER BIO INC NOTE 5.000% 6/0principal17,841,000$11.2M0

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CAPRCAPRICOR THERAPEUTICS INC4,099,900$98.7Mshares
WVEWAVE LIFE SCIENCES LTD600,000$3.49Mshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001214659-26-014410 base2026-11-16